Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1951 1
1952 1
1954 2
1955 3
1956 5
1957 3
1965 1
1966 3
1967 2
1968 1
1970 2
1971 2
1972 3
1975 1
1980 3
1987 2
1994 1
2001 1
2002 2
2003 1
2004 1
2005 6
2006 9
2007 14
2008 9
2009 10
2010 8
2011 11
2012 17
2013 13
2014 12
2015 13
2016 17
2017 19
2018 21
2019 17
2020 18
2021 20
2022 12
Text availability
Article attribute
Article type
Publication date

Search Results

252 results
Results by year
Filters applied: . Clear all
Page 1
An Overview of Targeted Alpha Therapy with 225Actinium and 213Bismuth.
Morgenstern A, Apostolidis C, Kratochwil C, Sathekge M, Krolicki L, Bruchertseifer F. Morgenstern A, et al. Curr Radiopharm. 2018;11(3):200-208. doi: 10.2174/1874471011666180502104524. Curr Radiopharm. 2018. PMID: 29732998 Free PMC article. Review.
Activity and Adverse Events of Actinium-225-PSMA-617 in Advanced Metastatic Castration-resistant Prostate Cancer After Failure of Lutetium-177-PSMA.
Feuerecker B, Tauber R, Knorr K, Heck M, Beheshti A, Seidl C, Bruchertseifer F, Pickhard A, Gafita A, Kratochwil C, Retz M, Gschwend JE, Weber WA, D'Alessandria C, Morgenstern A, Eiber M. Feuerecker B, et al. Among authors: morgenstern a. Eur Urol. 2021 Mar;79(3):343-350. doi: 10.1016/j.eururo.2020.11.013. Epub 2020 Dec 5. Eur Urol. 2021. PMID: 33293081
Supply and Clinical Application of Actinium-225 and Bismuth-213.
Morgenstern A, Apostolidis C, Bruchertseifer F. Morgenstern A, et al. Semin Nucl Med. 2020 Mar;50(2):119-123. doi: 10.1053/j.semnuclmed.2020.02.003. Epub 2020 Feb 21. Semin Nucl Med. 2020. PMID: 32172796 Free PMC article. Review.
Thawing Yedoma permafrost is a neglected nitrous oxide source.
Marushchak ME, Kerttula J, Diáková K, Faguet A, Gil J, Grosse G, Knoblauch C, Lashchinskiy N, Martikainen PJ, Morgenstern A, Nykamb M, Ronkainen JG, Siljanen HMP, van Delden L, Voigt C, Zimov N, Zimov S, Biasi C. Marushchak ME, et al. Among authors: morgenstern a. Nat Commun. 2021 Dec 7;12(1):7107. doi: 10.1038/s41467-021-27386-2. Nat Commun. 2021. PMID: 34876586 Free PMC article.
Production and Supply of α-Particle-Emitting Radionuclides for Targeted α-Therapy.
Radchenko V, Morgenstern A, Jalilian AR, Ramogida CF, Cutler C, Duchemin C, Hoehr C, Haddad F, Bruchertseifer F, Gausemel H, Yang H, Osso JA, Washiyama K, Czerwinski K, Leufgen K, Pruszyński M, Valzdorf O, Causey P, Schaffer P, Perron R, Maxim S, Wilbur DS, Stora T, Li Y. Radchenko V, et al. Among authors: morgenstern a. J Nucl Med. 2021 Nov;62(11):1495-1503. doi: 10.2967/jnumed.120.261016. Epub 2021 Jul 22. J Nucl Med. 2021. PMID: 34301779 Free PMC article.
First patient exceeding 5-year complete remission after 225Ac-PSMA-TAT.
Rathke H, Bruchertseifer F, Kratochwil C, Keller H, Giesel FL, Apostolidis C, Haberkorn U, Morgenstern A. Rathke H, et al. Among authors: morgenstern a. Eur J Nucl Med Mol Imaging. 2021 Jan;48(1):311-312. doi: 10.1007/s00259-020-04875-y. Epub 2020 May 28. Eur J Nucl Med Mol Imaging. 2021. PMID: 32468252 No abstract available.
[Alpha-Radioimmunotherapy: principle and relevance in anti-tumor immunity].
Ménager J, Gorin JB, Fichou N, Gouard S, Morgenstern A, Bruchertseifer F, Davodeau F, Kraeber-Bodéré F, Chérel M, Gaschet J, Guilloux Y. Ménager J, et al. Among authors: morgenstern a. Med Sci (Paris). 2016 Apr;32(4):362-9. doi: 10.1051/medsci/20163204014. Epub 2016 May 2. Med Sci (Paris). 2016. PMID: 27137693 Free article. Review. French.
252 results